Investor Relations

Corporate Governance

Corporate Governance

MediciNova, Inc. is committed to sound principles of corporate governance and is managed under the direction of its Board of Directors. Provided below is information concerning the charters that guide our Board committees, our code of business conduct and code of ethics, and other important corporate governance documents.
Committee Charters
Governance Documents

On November 13, 2010, the Board of Directors of MediciNova, Inc. granted a waiver under the Code of Conduct to Dr. Yuichi Iwaki, MediciNova's President and Chief Executive Officer, and another employee due to the appearance of a possible conflict of interest with respect to any joint real estate and banking transactions to which they were party as of November 13, 2010.